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Background: Bowel disorders have destructive impacts on the patients social and mental aspects of life and can
cause emotional distress. The risk of developing bowel incontinence also increases with age. The rate of incidence of
inflammatory bowel disease in Manitoba, Canada, has been unusually raised. Therefore, it is important to identify
trends in the incidence of bowel disorders that may suggest further epidemiological studies to identify risk factors and
identify any changes in important factors.
Methods: An important part of spatial epidemiology is cluster detection as it has the potential to identify possible
risk factors associated with disease, which in turn may lead to further investigations into the nature of diseases. To test
for potential disease clusters many methods have been proposed. The focused detection methods including the
circular spatial scan statistic (CSS), flexible spatial scan statistic (FSS), and Bayesian disease mapping (BYM) are among
the most popular disease detection procedures. A frequentist approach based on maximum likelihood estimation
(MLE) has been recently used to identify potential focused clusters as well. The aforementioned approaches are
studied by analyzing a dataset of bowel disorders in the province of Manitoba, Canada, from 2001 to 2010.
Results: The CSS method identified less regions than the FSS method in the south part of the province as potential
clusters. The same regions were identified by the BYM andMLE methods as being potential clusters of bowel disorders
with a slightly different order of significance. Most of these regions were also detected by the CSS or FSS methods.
Conclusions: Overall, we recommend using the methods BYM and MLE for cluster detection with the similar
population and structure of regions as in Manitoba. The potential clusters of bowel disorders are generally located in
the southern part of the province including the eastern part of the city of Winnipeg. These results may represent real
increases in bowel disorders or they may be an indication of other covariates that were not adjusted for in the model
used here. Further investigation is needed to examine these findings, and also to explore the cause of these increases.
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Background
Bowel disorders consist of a variety of diseases and
syndromes including Crohn’s disease, ulcerative colitis,
irritable bowel syndrome and bowel incontinence. Inflam-
matory bowel disease (IBD) includes Crohn’s disease and
ulcerative colitis and is distinguished by the presence
of chronic immunoinflammatory lesions in the large intes-
tine wall (ulcerative colitis) or anywhere in the gastroin-
testinal tract (Crohn’s disease) [1]. These diseases are
often diagnosed in early adulthood and are characterized
by a relapsing and remitting course. Treatment for the
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recurrent episodes of abdominal pain, diarrhea and bleed-
ing are necessary throughout the patients’ lifetime [2,3].
Since IBD is often diagnosed when the patients are still
fairly young and these diseases have recurrent episodes,
IBD can have a large negative affect on the patients’ quality
of life [2]. Although the cause of IBD is unknown, potential
risk factors include a family history of IBD (i.e., genetics),
a history of smoking, age (early adulthood) and people
who have been exposed to microorganisms early in life.
Individuals who were breastfed as a baby are less likely to
develop IBD. As well, people who have had an appendec-
tomy prior to diagnosis are less likely to develop ulcerative
colitis [4,5].
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Functional gastrointestinal disorders are characterized
by situations where there are recurrent symptoms, how-
ever, when examined there appears to be nothing wrong
[6]. Irritable bowel syndrome (IBS) is a functional bowel
disorder. IBS affects approximately 9% to 23% of the gen-
eral population. The symptoms of IBS are abdominal pain
or discomfort with a change in bowel function. Possi-
ble risk factors of IBS include genetics, stress, infection
and a poor diet [7]. The treatment is aimed at reduc-
ing the symptoms of IBS and may be treated by dietary
and lifestyle changes recommended by a doctor, pharma-
cotherapy, and psychosocial interventions [6,7].
Bowel incontinence is defined as the involuntary act of
having a bowel movement. This disorder has destructive
impacts on the patients social and mental aspects of life
and can cause emotional distress [8]. The risk of develop-
ing bowel incontinence increases with age. It is estimated
that between 2% and 18% of the general population and
50% of the people in nursing homes are affected by bowel
incontinence [8,9].
In addition to the deterioration of the patients’ quality of
life, bowel disorders including Crohn’s disease, ulcerative
colitis, irritable bowel syndrome, and bowel incontinence
have large negative economic impacts. An article from
1999 stated that Manitoba had unusually high rates of
incidence of inflammatory bowel disease [10]. Therefore,
it is important to identify trends in the incidence of bowel
disorders that may suggest further epidemiological stud-
ies to identify risk factors and identify any changes in
important factors. Trends may occur over a region and
the primary outcome measure of our paper is to examine
geographical variation in the number of people diagnosed
as having a bowel disorder during 2001 to 2010 in the
province of Manitoba, Canada.
A spatial cluster is a small region within the entire study
area which has a high number of disease cases relative
to the respective population [11]. Possible factors associ-
ated with disease may be found through the identification
of disease clusters. This may lead to an improved under-
standing of etiology, which in turn may lead to further
studies to find the link between exposures and disease
interventions [12].
There are two main groups of statistical cluster
detection methods, focused and non-focused (general).
Focused cluster detection methods identify regions with
a high number of disease occurrences in an area around
a potential cause (i.e., a toxic waste site) [13,14]. Non-
focused cluster detection methods are implemented in
order to find regions, in general, with high number of dis-
ease [15-17]. Focused cluster detection methods include
the circular spatial scan statistic (CSS) [18], flexible spa-
tial scan statistic (FSS) [19], and Bayesian disease mapping
(BYM) [15]. The Besag and Newell (BN) [20,21] test and
the maximizing excess event test (MEET) [22] are general
cluster detection methods. Non-focused tests are used to
discover possible clusters in the study area, while focused
tests are used to test the null hypothesis of no spatial clus-
ter against the alternative hypothesis that a spatial cluster
exists. Hence, the test statistics of focused tests (CSS, FSS
and BYM) are designed to detect a potential cluster in a
specific area of interest and the goal of non-focused tests
(BN and MEET) is to capture any significant cluster in
the entire study region without identifying a specific area
of interest. A comparison of these methods is given in
[23] with an application to childhood cancer in Alberta,
Canada.
This paper is centered around the focused cluster detec-
tion methods. The non-informative Bayesian approach
has become quite popular with advances in computational
power. The Bayesian approach can be used as a modeling
approach to identify the potential clusters. Data Cloning
(DC), which was proposed by Lele et al. [24], is a com-
puting algorithm to obtain maximum likelihood estimates
(MLE) and their standard errors for general hierarchical
models. Lele et al. [25] outlined a method to calculate
the prediction and prediction intervals for the random
effects in the class of generalised linear mixedmodels. The
MLE approach, via DC, was then proposed to identify the
possible clusters [26].
In this paper, the aforementioned focused approaches
(CSS, FSS, BYM, and MLE) are used to analyze a real
dataset of bowel disorders in the province of Manitoba,
Canada, from 2001 to 2010.
Methods
Study subjects
This study was based on the Canadian Community Health
Survey (CCHS) [27] from Statistics Canada. Informa-
tion is gathered from the Canadian population regarding
health status, health care utilization and health deter-
minants from the cross-sectional CCHS. In order to
provide reliable estimates at the health region level, the
CCHS collects data from individuals aged twelve and
older [27]. The number of people with bowel disor-
ders in the province of Manitoba, Canada, from 2001
to 2010 is the focus of this study. The province of
Manitoba is divided into five Regional Health Author-
ities which are further sub-divided into 67 Regional
Health Authority Districts (RHADs). The geographic
units used in our model are the RHADs and all of the
data used in the study are related to these geographic
boundaries. For simplicity, the RHADs are labelled
1, 2, . . . , 67. A population-based was also provided for
each RHAD. Since the bowel disorder data used in the
study came from a survey, appropriate weights estab-
lished by Statistics Canada [27] were applied to the data,
which was then aggregated over the study period from
2001 to 2010.
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The province of Manitoba’s population was steady over
the study periodwith approximately 1.15million people in
2001 to 1.20 million people in 2010. The average popula-
tion sizes varied across the regions with 920 people being
the smallest population in region 38 and 91,633 people
being the largest population size in region 62. The mean
and median population sizes in Manitoba were 17,471
and 9,466, respectively. The total number of people with
bowel disorders was 138,296 with a mean and median
of 2064 and 858 people, respectively. These observations
were based on the weighted results of people with bowel
disorders across the 67 regions in Manitoba.
Important factors required for focused spatial detection
approaches are the observed number of people with a
bowel disorder and the expected number of people with
a bowel disorder or the population size of each region.
If the expected number of people with bowel disorders
varies by different variables such as year, age, or gen-
der, adjustments may be made. In our application, the
expected number of disease cases was adjusted by year
(1-10), age group ((0-5),(6-20),(21-40),(41,88),(89+)) and
gender (male, female). The CSS, FSS, BYM, and MLE spa-
tial focused cluster detection methods are outlined in the
Appendix.
There are different assumptions for each of these four
focused spatial cluster detection methods. The CSS and
FSS approaches are distribution free, whereas, in the BYM
and MLE methods it is assumed that the number of dis-
ease cases follows a Poisson distribution. As well, in the
CSS and FSS approaches, the number of regions to be
included in a cluster needs to be specified, however, this
is not required for the BYM and MLE approaches. For
themodel-based cluster identificationmethods (BYM and
MLE), if the model does not fit the data well, the result
can be misleading. So, the deviance residual [28] should
be also checked.
Specific hypotheses
We specify the alternative hypotheses for the methods
CSS, FSS, BYM, and MLE. We consider multiple alterna-
tives that are tested separately. Further, let RRi indicate
the relative risk for the i-th region within clusters when
compared with the region outside clusters; the latter has
RRi = 1. For example for cluster X, the RRi is given by
RRi =
{
3 i ∈ X
1 otherwise
Results
The results of the four different cluster detection tech-
niques when applied to a bowel disorder dataset in the
province of Manitoba, Canada, from 2001 to 2010 are
shown and compared in this section.
Based on the 67 regions, four different clusters were
tested: (1) a case of no clusters (called A), (2) seven regions
from the north part of the province (called B), (3) seven
regions from south-central part of the province (called
C), and (4) 12 regions which consist Winnipeg region
(called D). For A, no region was specified as a potential
cluster. The regions for scenarios B, C, and D are B =
{31, 33, 34, 36, 38, 40, 41},C={27, 28, 29, 30, 50, 51, 52},D=
{56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67}, respectively.
In Figures 1, 2, 3, 4 the areas that are statistically sig-
nificant (potential clusters) are shown for each cluster
and each method separately. The summary of cluster A,
no region specified as a potential cluster, is presented in
Table 1. For the CSS and FSS methods, the regions that
are most likely, as well as second and third most likely to
be considered a cluster of disease are displayed. For the
BYM and MLE approaches, each region is ranked under
three criteria according to the lower limit of the credible/
prediction interval. For example, for the MLE result,
region 10 is most likely to be classified as a cluster of
disease while region 2 is least likely to be considered
as a cluster under the criteria that the lower bound of
prediction intervals of RR is greater than one.
The CSS and FSS methods identified some similar
regions as being potential clusters. In particular, the CSS
method identified 15 regions as possible clusters while the
FSS approach detected 18 regions as potential clusters of
bowel disorders. The same 19 regions were identified by
the BYM and MLE methods as being potential clusters of
bowel disorders with a slightly different order of signifi-
cance.Most of these regions were also detected by theCSS
or FSS methods. Note that evaluating the criterion of the
RR values from greater than 1 to 1.5 or even 2, the num-
ber of potential clusters decreases (Table 1). Based on the
deviance residual plots for both methods BYM and MLE,
we found that there is no serious lack of fit in the model.
For the case of cluster B, the methods BYM and MLE
were only able to detect the region 31 as a potential cluster
while the methods CSS and FSS also detected the region
38 as a potential cluster, noting that none of these four
methods detected the other five regions (33, 34, 36, 40, 41)
as a potential cluster.
For cluster C, the CSS and FSS methods detected 13
regions in addition to the cluster C as a potential clus-
ter. The BYM and MLE methods also detected 17 regions
in addition to the cluster C (except the region 52) as a
potential cluster.
For cluster D, the all four methods detected the D clus-
ter as a potential cluster. In addition to the regions in
Winnipeg (cluster D), the methods BYM and MLE were
also able to detect some neighbours of Winnipeg (13
regions) as potential clusters. However, the method CSS
only detected three regions 1,10, and 46 as a potential
cluster while the method FSS also detected the region 12
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Figure 1 The order of most likely clusters of bowel disorders for the CSS and FSSmethods, and the spatial effects of the regional bowel
disorder risks for the BYM and MLEmethods; in the case of cluster A.Major urban centre (Winnipeg region) is incorporated as inset.
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Figure 2 The order of most likely clusters of bowel disorders for the CSS and FSSmethods, and the spatial effects of the regional bowel
disorder risks for the BYM andMLEmethods; in the case of cluster B.Major urban centre (Winnipeg region) is incorporated as inset.
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Figure 3 The order of most likely clusters of bowel disorders for the CSS and FSSmethods, and the spatial effects of the regional bowel
disorder risks for the BYM and MLEmethods; in the case of cluster C.Major urban centre (Winnipeg region) is incorporated as inset.
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Figure 4 The order of most likely clusters of bowel disorders for the CSS and FSSmethods, and the spatial effects of the regional bowel
disorder risks for the BYM andMLEmethods; in the case of cluster D.Major urban centre (Winnipeg region) is incorporated as inset.
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as a potential cluster in addition to regions detected by the
CSS method.
Discussion and conclusion
The four methods CSS, FSS, BYM, and MLE were stud-
ied with potential for detecting clusters with high ratio
of bowel disorders in the province of Manitoba, Canada.
These four methods have been extensively used in the lit-
erature and are relatively comprehensive. These methods
use different approaches (semi-parametric to parametric)
to test for significant clusters.
We considered four different alternative hypotheses to
compare the results of different methods. In general, the
CSS method identified a lower number of regions com-
bined as a potential cluster compared to FSS method, due
to non-circular shape of some regions in the province of
Manitoba. It also seems that the bowel disorder cases tend
to constitute the potential clusters in south-central part of
the province. Note that we used four different alternative
hypotheses (with low and high dense regions in terms of
population) to compare these four methods, however, one
can also use an extensive simulation study to compare the
performance of these four methods.
Themethods BYM andMLE did good jobs for dispersed
population (cluster B) and also for dense population (clus-
ters C and D) compared to the methods CSS and FSS.
Also, in our study, the method FSS did a better job com-
pared to the method CSS to detect potential clusters.
Overall, we recommend using the methods BYM and
MLE for cluster detection for the similar population and
structure of regions as in Manitoba.
A region was identified as a potential cluster if the
credible/prediction interval of the estimated relative risk
was larger than one for the BYM and MLE approaches.
Table 1 The order of significant regions of themethods CSS, FSS, BYM, andMLE for cluster A
Method
Region
RR > 1.0 RR > 1.5 RR > 2.0
CSS FSS BYM MLE BYM MLE BYM MLE
1 3 3 3 3 3 3 3 3
2 - 3 19 19 - - - -
3 - 3 - - - - - -
5 - - 5 5 5 5 - -
10 1 1 1 1 1 1 1 1
11 1 1 7 8 7 8 - -
12 1 1 6 6 6 6 - -
13 1 - - - - - - -
15 1 - - - - - - -
16 1 - - - - - - -
17 1 1 16 15 - - - -
18 1 - - - - - - -
20 - 3 9 9 - - - -
22 1 1 13 12 - - - -
27 - 3 14 14 - - - -
28 - 3 - - - - - -
43 - 2 4 4 4 4 - -
46 2 2 2 2 2 2 2 2
47 - 2 - - - - - -
50 - - 10 10 - - - -
58 - - 18 18 - - - -
59 1 1 8 7 8 7 - -
60 1 1 17 17 - - - -
61 1 1 11 11 - - - -
62 1 1 12 13 - - - -
67 - - 15 16 - - - -
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Different decision rules may be defined where the esti-
mated relative risk (in terms of the credible/prediction
interval) would be larger or smaller than one [29]. One
could also consider the exceedance probability Pr(RRi >
b) > c, where b can be 1, 2 or 3 and c might be a large
value such as 0.90 [30].
Here, three important factors, age, gender and year
were used to adjust the expected number of bowel dis-
orders in the province of Manitoba. Unlike the meth-
ods CSS and FSS methods, we can extend the model
(2)-(3), for both BYM and MLE methods, to include
other covariates directly which may be required for some
applications.
We also note that the methods have different settings
and assumptions which motivate our comparison. User-
chosen settings are part of all cluster tests and different
choices could lead to different results. All four methods
have been proposed for local clusters. Under the null
hypothesis, the number of bowel disorder cases follows
a Poisson distribution for the BYM and MLE methods,
while the test statistic for the CSS and FSSmethods has an
asymptotically χ2 distribution. These features motivated
us to consider these important methods and apply them
to our bowel disorder cases.
As limitations of study, we assumed that our bowel dis-
order cases are rare cases to be able to use Poisson model
in our BYM and MLE methods. We used survey data
(weighted to the population level) in our study. Strengths
of the study include the evaluation of multiple cluster
detection methods.
The potential clusters of bowel disorders are generally
located in the southern part of the province including the
eastern part of the city of Winnipeg (cluster A). These
results may represent real increases in bowel disorders or
theymay be an indication of other covariates that were not
adjusted for in the model used here. Further investigation
is needed to examine these findings, and also to explore
the cause of these increases.
Appendix
The CSS, FSS, BYM, and MLE spatial focused cluster
detection methods are outlined below.
Circular spatial scan statistic (CSS)
The spatial scan statistic has a variety of applications
in the epidemiology field [31]. With the circular spatial
scan statistic, a circular window S is imposed on each
region. The radius of the circle ranges from zero to a
pre-determinedmaximum distance d or a pre-determined
maximum number of regions J to be considered in
the cluster. The window made up of the (j − 1)-th
nearest neighbours to region i is denoted by Si:j(j =
1, . . . , J). The set of all windows to be scanned by
the circular spatial scan statistic is denoted by S1 =
{
Si:j; i = 1, ...,m; j = 1, ..., J
}
. A likelihood ratio statistic is
calculated for each circle and is based on the number of
observed and expected cases inside and outside the circle.
The likelihood under the null and alternative hypotheses
are denoted by L0 and Li(i = 1, ...,m), respectively,
where the null hypothesis states that there is no cluster
in region i and the alternative hypothesis is there exists
a cluster in region i based on its j-th nearest neighbours.








)Ci (N − Ci
N − Ei
)N−Ci
I(Ci > Ei), (1)
where the observed number of cases and expected num-
ber of cases inside a circle are denoted by Ci and Ei,
respectively and the observed number and expected num-
ber of cases outside a circle are denoted by (N − Ci) and
(N −Ei), respectively. The indicator function I(Ci > Ei) is
equal to 1 whenCi > Ei and 0 otherwise. Potential clusters
are identified by circles with high likelihood ratio statistics
[18].
This method can be conducted using SaTScan [32] or
FleXScan [33] software. The J is usually chosen to encom-
pass at most 50% of the population at risk, however, we
used J = 15, which is the FleXScan default. The region
centroid had to be included in the radius of the circle in
order for the region to be part of the circle.
Flexible spatial scan statistic (FSS)
The flexible spatial scan statistic is similar to the method
of the CSS except now the detected cluster is flexible
in shape while still being bound to a small neighbour-
hood of each region. An irregularly shaped window S
is placed on each region by the flexible scan statistic.
This is done by connecting its adjacent regions. For any
region i, the set of irregularly shaped windows of length
j, which contains j connected regions including region i,
can vary from 1 to the pre-specified maximum J, where
J is the maximum length of a cluster. In order to avoid
unlikely cluster shapes, the joined regions are confined to
the subsets of the set of regions i and (J − 1)-th near-
est neighbours of region i. The set of all windows to
be scanned by the flexible spatial scan statistic is then
S2 =
{
Si:j(k); i = 1, . . . ,m; j = 1, . . . , J ; k = 1, . . . , kij
}
. The
size of S2 is much larger than S1 which is at mostmJ. This
is because for each region i the flexible scan statistic stud-
ies J circles plus all the sets of connected regions whose
centroids are found within the J-th largest concentric cir-
cle, whereas the circular scan statistic considers only J
circles for each region i. The likelihood ratio in (1) can be
used for the flexible spatial scan statistic where the cir-
cle defined in (1) now refers to S2 rather than S1. As with
the CSS method, circles with high likelihood ratio val-
ues are considered to be possible areas of disease clusters
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[19]. The FSS method is conducted using the FleXScan
software [33], with J = 15, which is the FleXScan default.
Bayesian diseasemapping (BYM)
Another approach for cluster detection is a Bayesian
method using Markov chain Monte Carlo (MCMC) sam-
pling [15,16,34,35]. Bayesian disease mapping (BYM) was
first used by Besag et al. [15]. Two parts are included in
the model. First, the cases are assumed to follow a Poisson
distribution with an area specific parameter θiEi:
Ci ∼ Poisson(θiEi), (2)
where the observed and expected number of cases in
region i are denoted byCi and Ei, respectively. The second
part of the model comes from
log(θi) = μ + ηi, (3)
where the relative risk (RR) in region i is given by θi, μ
represents the overall mean ratio over the entire region
and the spatially correlated random effects are denoted
by ηi. The spatial random effects are found using the
usual conditional autoregressive (CAR) model. However,
many CAR models may be used by attaining a col-
lection of mutually compatible conditional distributions
p(ηi|η−i), i = 1, . . . ,m where η−i = {ηj : j = i, j ∈ ∂i} and
∂i refers to a set of neighbours for the i-th region [15]. The
general model for the spatial effects ηi is
η = (η1, . . . , ηm)′ ∼ N(0,η),
η = σ 2η (Im − ληD)−1P,
where P is a m × m diagonal matrix with elements
Pii = 1/Ei; D is a m × m matrix with elements Dij =
(Ej/Ei)1/2 if region i and j are adjacent and Dij = 0 other-
wise; σ 2η is the spatial dispersion parameter; λη measures
the spatial autocorrelation, λmin ≤ λη ≤ λmax, where
λ−1min and λ−1max are the smallest and largest eigenvalues of
P−1/2DP1/2; and Im is an identity matrix of dimension m.
We refer to [36] for details of this proper CAR model.
Within the Bayesian framework (MCMC) the parame-
ters can be estimated using vague prior distributions. This
produces posterior distributions for the parameters in the
model given in (2)-(3) [15].
In terms of their credibility sets, when the estimated rel-
ative risk is significantly larger than one (i.e., the lower
level of the credible set is larger than one) the region is
considered to be a disease cluster [37].WinBUGS software
[36] was used to conduct this method and to calculate the
relative risk values.
Frequentist approach usingMLE for diseasemapping (MLE)
The DC approach is based on the Bayesian computational
method which is used for frequentist purposes. When
using the DC approach, the observationsC = (C1, ...,Cm)′
are repeated independently by L different individuals.
These individuals all obtain the exact same set of observa-
tions C which are denoted by C(L) = (C,C, . . . ,C). The
posterior distribution of α = (μ, λη, σ 2η )′ conditional on









where the prior distribution on the parameter space is
π(α) and H(C(L)) = ∫ {L(α;C)}Lπ(α)dα is the normal-
izing constant. The likelihood for L copies of the original
data is denoted by {L(α;C)}L. It was shown by Lele et al.
[24,25] that when L is large enough, πL(α|C(L)) will con-
verge to a multivariate Normal distribution with the mean
given by the MLE of the model parameters and variance-
covariance matrix equal to 1/L times the inverse of the
Fisher information matrix for the MLE. For large L, this
distribution is almost degenerate at the MLE α. In addi-
tion, an estimate of the MLE is given by the sample mean
vector of the generated random numbers and L times
their sample variance-covariance matrix is an estimate of
the asymptotic variance-covariance matrix for the MLE
αˆ. Different tests to determine the adequate number of
clones L were also provided by Lele et al. [25].
Predictionof relative risk
From a frequentist point of view, the prediction of the rel-
ative risk (random effects) is usually difficult. When α is
estimated using the data, one approach is to use π(R =
r|C, αˆ) where R = (RR1, . . . ,RRm)′, however, this method
does not take into account the variability introduced by
themodel parameters estimate. In order to account for the
variation of the estimator, one method that has been pro-





(C|r, α1)g(r|α2)φ(α, αˆ, I−1(αˆ)) dα
H(C) , (5)
where α1 = μ, α2 = (λη, σ 2η )′, f (·) and g(·) are Poisson
and Normal distributions, φ(., ξ ,) denotes a multivari-
ate Normal density with mean ξ and variance-covariance
 and H(C) = ∫ L(α;C)π(α)dα is the normalizing con-
stant. Using the density given in equation (5) and MCMC
sampling, the prediction of the r is found. Similar to the
BYM method, a region where the estimated relative risk
(in terms of their prediction interval) is significantly larger
than one is considered to be a disease cluster. In order to
calculate the relative risk values, the dclone package [39]
is used in the R software [40].
Competing interests
The author declares that he has no competing interests.
Acknowledgements
I would like to thank two referees for constructive comments and suggestions,
which led to an improved version of the manuscript. This work was supported
by grants from the Manitoba Health Research Council (MHRC) and the Natural
Torabi BMC Public Health 2014, 14:285 Page 11 of 11
http://www.biomedcentral.com/1471-2458/14/285
Sciences and Engineering Research Council of Canada (NSERC). The author
thanks Katie Galloway for manuscript preparation.
Received: 17 September 2013 Accepted: 19 March 2014
Published: 27 March 2014
References
1. Casellas F, Ginard D, Vera I, Torrejón A: Satisfaction of the health care
professionals managing patients with inflammatory bowel disease.
J Crohns Colitis 2013, 7:e249–e255.
2. Feagan BG: Review article: economic issues in Crohn’s disease -
assessing the effects of new treatments on health-related quality of
life. Ailment Phrarmocol Ther 1999, 13(Suppl. 4):29–37.
3. Longobardi T, Jacobs P, Wu L, Bernstein CN:Work losses related to
inflammatory bowel disease in Canada: results from a national
population health survey. Am J Gastroenterol 2003, 98(4):844–849.
4. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF: A
population-based case control study of potential risk factors for
IBD. Am J Gastroenterol 2006, 101:993–1002.
5. Molodecky NA, Kaplan GG: Environmental risk factors for
inflammatory bowel disease. Gastroenterol Hepatol 2010, 6(5):339–346.
6. Hyams JS: Functional gastrointestinal disorders. Curr Opin Pediatr
1999, 11:375–378.
7. Schwetz I, Chang L: Irritable bowel syndrome. In Encyclopedia of
Gastroenterology. Edited by Johnson L. New York: Elsevier; 2004:467–475.
8. Norton C, Dibley LB, Bassett P: Faecal incontinence in inflammatory
bowel disease: associations and effect on quality of life. J Crohns
Colitis 2013, 7:e302–e311.
9. Crowell MD, Schettler VA, Brian E. Lacy BE, Lunsford TN, Harris LA, DiBaise
JK, Jones MP: Impact of anal incontinence on psychosocial function
and health-related quality of life. Dig Dis Sci 2007, 52:1627–1631.
10. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A: Epidemiology of
Crohn’s disease and ulcerative colitis in a central Canadian province:
a population-based study. Am J Epidemiol 1999, 149(10):916–924.
11. Lawson AB: Statistical Methods in Spatial Epidemiology, 2nd edition.
London: John Wiley & Sons, Ltd; 2006.
12. Jennings JM, Curriero FC, Celentano D, Ellen JM: Geographic
identification of high gonorrhea transmission areas in Baltimore,
Maryland. Am J Epid 2005, 161:73–80.
13. Elliott P, Briggs D, Morris S, de Hoogh C, Hurt C, Jensen TK, Maitland I,
Richardson S, Wakefield J, Jarup L: Risk of adverse birth outcomes in
populations living near landfill sites. Br Med J 2001, 323:363–368.
14. Lawson AB, Biggeri A, Williams FLR: A review of modeling approaches
in health risk assessment around putative sources. In DiseaseMapping
and Risk Assessment for Public Health. Edited by Lawson AB, Biggeri A
BöhningD, Lesaffre E, Viel J, Bertollini R. New York: Wiley; 1999:231–245.
15. Besag JE, York JC, Mollìe A: Bayesian image restoration with two
applications in spatial statistics (with discussion). Ann Inst Statist Math
1991, 43:1–59.
16. Clayton D, Bernardinelli L: Bayesianmethods for mapping disease risk.
In Geographical and environmental epidemiology: methods for small-area
studies. Edited by Elliott P, Cuzick J, English D, Stern R. Oxford University
Press; 1996:205–220.
17. Clayton D, Kaldor J: Empirical Bayes estimates of age-standardized
relative risks for use in disease mapping. Biometrics 1987, 43:671–681.
18. Kulldorff M: A spatial scan statistics. CommStatist: Theor Meth 1997,
26:1481–1496.
19. Tango T, Takahashi K: A flexibly shaped spatial scan statistic for
detecting clusters. Int J Health Geogr 2005, 4(11):1–15.
20. Besag JE, Newell J: The detection of clusters in rare diseases. J Roy
Statist Soc Ser A 1991, 154:143–155.
21. Torabi M, Rosychuk RJ: Spatial event cluster detection using an
approximate normal distribution. Int J Health Geogr 2008, 7(61):1–22.
22. Tango T: A test for spatial disease clustering adjusted for multiple
testing. Statist Med 2000, 19:191–204.
23. Torabi M, Rosychuk RJ: An examination of five spatial disease
clustering methodologies for the identification of childhood cancer
clusters in Alberta, Canada. Spat Spatio-tempor Epidemiol 2011,
2:321–330.
24. Lele SR, Dennis B, Lutscher F: Data cloning: easy maximum likelihood
estimation for complex ecological models using BayesianMarkov
chain Monte Carlo methods. Ecol Lett 2007, 10:551–563.
25. Lele SR, Nadeem K, Schmuland B: Estimability and likelihood inference
for generalized linear mixedmodels using data cloning. J Am Statist
Assoc 2010, 105:1617–1625.
26. Torabi M: Spatial disease cluster detection: an application to
childohhod asthma inManitoba, Canada. J Biomet Biostat 2012,
S7:1010. doi:10.4172/2155-6180.S7-010
27. Statistics Canada: Canadian Community Health Survey User Guide. Ottawa
ON: Statistics Canada. 2001–2010.
28. McCullagh P, Nelder JA: Generalized Linear Models, 2nd ed. London:
Chapman and Hall; 1989.
29. Richardson S, Thomson A, Best N, Elliott P: Interpreting posterior risk
estimates in disease-mapping studies. Environ Health Persp 2004,
112(9):1016–1025.
30. Banerjee S, Gelfand AE, Carlin BP: Hierarchical Modeling and Analysis for
Spatial Data. London: Chapman and Hall; 2004.
31. Fukuda Y, Umezaki M, Nakamura K, Takano T: ariations in social
characteristics of spatial disease clusters: examples of colon, lung
and breast cancer in Japan. Int J Health Geogr 2005, 4(16):1–13.
32. Kulldorff M, Rand K, Gherman G, Williams G, DeFrancesco D, SaTScan
V2. 1: Software for the Spatial and Space-time Scan Statistics. Bethesda:
National Centre Institute; 1998.
33. Takahashi K, Yokoyama T, Tango T: FleXScan: Software for the Flexible Scan
Statistic. Japan: National Institute of Public Health; 2006.
34. Bernardinelli L, Montomoli C: Empirical Bayes versus fully Bayesian
analysis of geographical variation in disease risk. Statist Med 1992,
11:983–1007.
35. Gilks WR, Richardson S, Spielhalter DJ (Eds):Markov chain Monte Carlo in
Practice. New York: Springer-Verlag; 1996.
36. Spiegelhalter D, Thomas A, Best N, Lunn D: WinBUGS version 1.4 User
Manual. London: MRC Biostatistics unit, Institute of Public Health; 2004.
37. Aamodt G, Samuelsen SO, Skrondal A: A simulated study of three
methods for detecting disease clusters. Int J Health Geogr 2006,
5(15):1–11.
38. Hamilton JD: A standard error for the estimated state vector of a
state-spacemodel. J Economet 1986, 33:387–397.
39. Sólymos P: dclone: Data cloning in R. The R J 2010, 2:29–37.
40. R Core Team: R: A Language and Environment for Statistical Computing.
Vienna: Austria: R Foundation for Statistical Computing; 2013.
http://www.R-project.org
doi:10.1186/1471-2458-14-285
Cite this article as: Torabi: Bowel disorders and its spatial trend in
Manitoba, Canada. BMC Public Health 2014 14:285.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
